Heart Disease Clinical Trials in Georgia

Showing 281-300 of 427 trials

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

NCT01953874

The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and sleep.

Acute Decompensated Heart FailureSleep Disordered Breathing

ResMed126 participantsStarted Dec 2013

Huntsville, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +12 more locations

COMPLETEDPhase 314 miles

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

NCT00088179

During a heart bypass procedure, a substance called "complement" is activated by the body. This "complement activation" causes an inflammatory response that can lead to side affects such as chest pain, heart attacks, stroke, heart failure, or death. The purpose of this study is to find out if the study drug (pexelizumab), that blocks "complement activation," can reduce such side effects and be given safely to patients requiring the bypass procedure with the use of the heart-lung machine.

Coronary Artery Disease

Alexion Pharmaceuticals, Inc.4,000 participantsStarted Jul 2004

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +185 more locations

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Heart Disease Trials in Other Cities

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

CANVAS - CANagliflozin cardioVascular Assessment Study

Decisional Quality for Patients With Coronary Artery Disease

Sapphire II PRO US Clinical Study

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis

To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Global Non-interventional Heart Failure Disease Registry

An Assessment of the Glider Balloon in Complex Lesions

Vascular Inflammation in Psoriasis - Extension Study

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Other Conditions in Georgia